Fresenius (FRE) SdK Anlegerforum presentation summary

Mission and vision

• Committed to saving lives, improving health, and providing access to affordable, innovative medical products and care.

• Aims to be a trusted leader in healthcare by combining advanced technology with patient-centric approaches.

Strategic focus and market trends

• Focuses on future healthcare trends: equity, broad access, integrated therapies, and AI-driven clinical decisions.

• Aging populations, rising healthcare spending, and increasing chronic diseases drive long-term sector growth.

• Anticipates a global shortage of 10 million healthcare workers by 2030.

Business segments and market position

• Operates through Fresenius Kabi (pharma, biopharma, nutrition, medtech) and Fresenius Helios (hospital operations).

• Kabi leads globally in parenteral nutrition and IV drugs, with strong growth in biopharma and a robust product pipeline.

• Helios is the top private hospital operator in Germany and Spain, with high market share and quality accreditation.